REGENXBIO Inc. (Nasdaq: RGNX) announced an exclusive worldwide license agreement with Biogen (Nasdaq: BIIB) for the development of gene therapy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE